The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease

Neurology

Volumn 84, Issue 19, 2015, Pages 1956-1963

  Tahmasian, Masoud ^a,b,d,e   Pasquini, Lorenzo ^a,b   Scherr, Martin ^a,b,f   Meng, Chun ^a,b,c   Förster, Stefan ^a,b   Mulej Bratec, Satja ^a,b,c   Shi, Kuangyu ^a   Yakushev, Igor ^a,b   Schwaiger, Markus ^a   Grimmer, Timo ^a   Diehl Schmid, Janine ^a   Riedl, Valentin ^a,b   Sorg, Christian ^a,b   Drzezga, Alexander ^a,d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

AGED; ALZHEIMER DISEASE; ANGULAR GYRUS; ARTICLE; BOLD SIGNAL; BRAIN ATROPHY; BRAIN METABOLISM; BRAIN REGION; BRAIN SIZE; CONNECTOME; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; PATHOPHYSIOLOGY; PET-MRI SCANNER; POSITRON EMISSION TOMOGRAPHY; PRECUNEUS; PRIORITY JOURNAL; RESTING STATE NETWORK; VOXEL BASED MORPHOMETRY; WHITE MATTER; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC USE; METABOLISM; MIDDLE AGED; NERVE CELL NETWORK; PARIETAL LOBE; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ALZHEIMER DISEASE; CONNECTOME; FEMALE; FLUORODEOXYGLUCOSE F18; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NERVE NET; PARIETAL LOBE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84929192386     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001575     Document Type: Article

References (40)

1. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann NY Acad Sci 2008;1124:1-38.
2. Sorg C, Riedl V, Muhlau M, et al. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci USA 2007; 104:18760-18765.
3. Greicius MD, Srivastava G, Reiss AL, Menon V. Defaultmode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 2004;101:4637-4642.
4. Sperling RA, Laviolette PS, O'Keefe K, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009;63:178-188.
5. Drzezga A, Becker JA, Van Dijk KR, et al. Neuronal dysfunction and disconnection of cortical hubs in nondemented subjects with elevated amyloid burden. Brain 2011;134:1635-1646.
6. Myers N, Pasquini L, Gottler J, et al. Within-patient correspondence of amyloid-beta and intrinsic network connectivity in Alzheimer's disease. Brain 2014;137: 2052-2064.
7. Braak H, Braak E. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol 1991;82:239-259.
8. Sperling RA, Dickerson BC, Pihlajamaki M, et al. Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med 2010;12:27-43.
9. Putcha D, Brickhouse M, O'Keefe K, et al. Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults. J Neurosci 2011;31:17680-17688.
10. Bakker A, Krauss GL, Albert MS, et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron 2012;74:467-474.
11. Pasquini L, Scherr M, Tahmasian M, et al. Link between hippocampus' raised local and eased global intrinsic connectivity in AD. Alzheimers Dement Epub 2014 Jul 17.
12. Das SR, Pluta J, Mancuso L, et al. Increased functional connectivity within medial temporal lobe in mild cognitive impairment. Hippocampus 2013;23:1-6.
13. Yassa MA, Mattfeld AT, Stark SM, Stark CE. Age-related memory deficits linked to circuit-specific disruptions in the hippocampus. Proc Natl Acad Sci USA 2011;108: 8873-8878.
14. Raichle ME, Mintun MA. Brain work and brain imaging. Annu Rev Neurosci 2006;29:449-476.
15. Magistretti PJ, Pellerin L. The contribution of astrocytes to the 18F-2-deoxyglucose signal in PET activation studies. Mol Psychiatry 1996;1:445-452.
16. Tahmasian M, Knight DC, Manoliu A, et al. Aberrant intrinsic connectivity of hippocampus and amygdala overlap in the fronto-insular and dorsomedial-prefrontal cortex in major depressive disorder. Front Hum Neurosci 2013;7:639.
17. Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005;26:839-851.
18. Gelb DJ, St Laurent RT. Clinical Dementia Rating. Neurology 1994;44:1983-1984.
19. Welsh KA, Butters N, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part V: a normative study of the neuropsychological battery. Neurology 1994;44:609-614.
20. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet 2006;367:1262-1270.
21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
22. Riedl V, Bienkowska K, Strobel C, et al. Local activity determines functional connectivity in the resting human brain: a simultaneous FDG-PET/fMRI study. J Neurosci 2014;34:6260-6266.
23. Van Dijk KR, Sabuncu MR, Buckner RL. The influence of head motion on intrinsic functional connectivity MRI. Neuroimage 2012;59:431-438.
24. Sheline YI, Raichle ME, Snyder AZ, et al. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry 2010;67:584-587.
25. Chetelat G, Desgranges B, Landeau B, et al. Direct voxelbased comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain 2008;131:60-71.
26. Drzezga A, Grimmer T, Henriksen G, et al. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. Neuroimage 2008;39:619-633.
27. Mevel K, Desgranges B, Baron JC, et al. Detecting hippocampal hypometabolism in mild cognitive impairment using automatic voxel-based approaches. Neuroimage 2007;37:18-25.
28. Marrelec G, Krainik A, Duffau H, et al. Partial correlation for functional brain interactivity investigation in functional MRI. Neuroimage 2006;32:228-237.
29. Behzadi Y, Restom K, Liau J, et al. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. Neuroimage 2007;37:90-101.
30. Yan CG, Craddock RC, Zuo XN, et al. Standardizing the intrinsic brain: towards robust measurement of inter-individual variation in 1000 functional connectomes. Neuroimage 2013;80:246-262.
31. Samuraki M, Matsunari I, Chen WP, et al. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease. Eur J Nucl Med Mol Imaging 2007;34:1658-1669.
32. Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E. Relatively preserved hippocampal glucose metabolism in mild Alzheimer's disease. Dement Geriatr Cogn Disord 1998;9:317-322.
33. Villain N, Fouquet M, Baron JC, et al. Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. Brain 2010;133:3301-3314.
34. Kim J, Kim YH, Lee JH. Hippocampus-precuneus functional connectivity as an early sign of Alzheimer's disease: a preliminary study using structural and functional magnetic resonance imaging data. Brain Res 2013;1495:18-29.
35. Squire LR, Stark CE, Clark RE. The medial temporal lobe. Annu Rev Neurosci 2004;27:279-306.
36. Yakushev I, Schreckenberger M, Muller MJ, et al. Functional implications of hippocampal degeneration in early Alzheimer's disease: a combined DTI and PET study. Eur J Nucl Med Mol Imaging 2011;38:2219-2227.
37. Mackenzie IR, Miller LA. Senile plaques in temporal lobe epilepsy. Acta Neuropathol 1994;87:504-510.
38. Palop JJ, Mucke L. Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin? Neuromolecular Med 2010;12:48-55.
39. Busche MA, Chen X, Henning HA, et al. Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2012;109:8740-8745.
40. DeVos SL, Goncharoff DK, Chen G, et al. Antisense reduction of tau in adult mice protects against seizures. J Neurosci 2013;33:12887-12897.